BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23300160)

  • 1. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial.
    Omer SB; Zaman K; Roy E; Arifeen SE; Raqib R; Noory L; Seib K; Breiman RF; Steinhoff MC
    J Infect Dis; 2013 Apr; 207(7):1144-7. PubMed ID: 23300160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.
    van Santen KL; Bednarczyk RA; Adjaye-Gbewonyo D; Orenstein WA; Davis R; Omer SB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1180-4. PubMed ID: 23856786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.
    Jansen AG; Sanders EA; Hoes AW; van Loon AM; Hak E
    J Pediatr; 2008 Dec; 153(6):764-70. PubMed ID: 18621393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: a randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recurrent respiratory tract infections.
    Schönbeck Y; Sanders EA; Hoes AW; Schilder AG; Verheij TJ; Hak E
    Vaccine; 2005 Sep; 23(41):4906-14. PubMed ID: 16005552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of maternal influenza immunization in mothers and infants.
    Zaman K; Roy E; Arifeen SE; Rahman M; Raqib R; Wilson E; Omer SB; Shahid NS; Breiman RF; Steinhoff MC
    N Engl J Med; 2008 Oct; 359(15):1555-64. PubMed ID: 18799552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza season triggers pneumococcal vaccination.
    Goebel LJ; Mufson MA
    J Am Geriatr Soc; 2006 Aug; 54(8):1261-4. PubMed ID: 16913996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
    Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants.
    Black SB; Shinefield HR; France EK; Fireman BH; Platt ST; Shay D;
    Am J Perinatol; 2004 Aug; 21(6):333-9. PubMed ID: 15311370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oil-in-water emulsion adjuvant with influenza vaccine in young children.
    Vesikari T; Knuf M; Wutzler P; Karvonen A; Kieninger-Baum D; Schmitt HJ; Baehner F; Borkowski A; Tsai TF; Clemens R
    N Engl J Med; 2011 Oct; 365(15):1406-16. PubMed ID: 21995388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal.
    Tielsch JM; Steinhoff M; Katz J; Englund JA; Kuypers J; Khatry SK; Shrestha L; LeClerq SC
    BMC Pregnancy Childbirth; 2015 Feb; 15():40. PubMed ID: 25879974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
    McBean AM; Jung K; Hebert PL
    Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
    Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
    JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.